Another longitudinal analysis conducted in 71 COVID-19 patients revealed that a combination of IL-10, RANTES, and IL-1 receptor antagonist at first week of follow-up might be useful prediction biomarkers for patients’ outcome [33]. Here, IL10 is linked to COVID-19.